All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AILERON THERAPEUTICS INC Last Reported: 9/30/2021 Stock Symbol: ALRN

Business Address

285 SUMMER STREET
UNIT 101
BOSTON, MA US 02210

Mailing Address

285 SUMMER STREET
UNIT 101
BOSTON, MA US 02210
Phone Number: 617-995-0900 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 12/31/2014
Cash and Cash Equivalents $7,603,000.00 $10,748,000.00 $7,046,000.00 $7,850,000.00 $17,124,000.00 $10,697,000.00 $5,311,000.00 $6,867,000.00 $10,157,000.00 $11,272,000.00 $10,635,000.00 $7,716,000.00 $11,980,000.00 $6,782,000.00 $11,863,000.00 $13,428,000.00 $9,397,000.00 -- $20,715,000.00 $4,504,000.00 $3,885,000.00 -- $3,768,000.00 $6,208,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $2,166,000.00 $648,000.00 $1,928,000.00 $1,828,000.00 $765,000.00 $967,000.00 $1,247,000.00 $1,911,000.00 $1,012,000.00 $1,094,000.00 $1,055,000.00 $2,083,000.00 $1,390,000.00 $1,067,000.00 $1,000,000.00 $1,164,000.00 $561,000.00 -- $333,000.00 -- -- -- -- --
Total Current Assets $54,423,000.00 $60,152,000.00 $16,326,000.00 $15,974,000.00 $19,670,000.00 $13,687,000.00 $19,550,000.00 $26,497,000.00 $32,559,000.00 $14,389,000.00 $21,775,000.00 $30,053,000.00 $37,206,000.00 $44,446,000.00 $51,840,000.00 $58,117,000.00 $11,992,000.00 -- $21,073,000.00 -- -- -- -- --
Property Plant and Equipement $144,000.00 $153,000.00 $15,000.00 $147,000.00 $164,000.00 $225,000.00 $295,000.00 $361,000.00 $379,000.00 $398,000.00 $7,290,000.00 $6,832,000.00 $4,123,000.00 $134,000.00 $154,000.00 $111,000.00 $109,000.00 -- $107,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $24,000.00 $24,000.00 -- -- -- -- -- $302,000.00 $302,000.00 $501,000.00 $679,000.00 $680,000.00 $680,000.00 $683,000.00 $694,000.00 $808,000.00 $782,000.00 -- $778,000.00 -- -- -- -- --
Total Assets $54,768,000.00 $60,531,000.00 $16,341,000.00 $22,239,000.00 $26,125,000.00 $20,373,000.00 $26,473,000.00 $33,952,000.00 $40,193,000.00 $22,399,000.00 $30,312,000.00 $38,133,000.00 $42,577,000.00 $45,831,000.00 $52,688,000.00 $59,036,000.00 $15,105,000.00 -- $22,021,000.00 -- -- -- -- --
Accounts Payable $1,035,000.00 $1,016,000.00 $1,596,000.00 $1,002,000.00 $993,000.00 $1,088,000.00 $1,452,000.00 $2,349,000.00 $1,719,000.00 $858,000.00 $1,731,000.00 $2,994,000.00 $1,583,000.00 $1,796,000.00 $1,600,000.00 $1,650,000.00 $2,212,000.00 -- $1,971,000.00 -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $4,659,000.00 $4,401,000.00 $4,179,000.00 $9,781,000.00 $9,471,000.00 $10,604,000.00 $10,425,000.00 $11,136,000.00 $10,209,000.00 $9,552,000.00 $10,712,000.00 $12,102,000.00 $9,709,000.00 $4,856,000.00 $4,891,000.00 $5,023,000.00 $5,471,000.00 -- $4,082,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $288,674,000.00 $287,987,000.00 $231,412,000.00 $226,715,000.00 $225,890,000.00 $214,625,000.00 $214,148,000.00 $213,671,000.00 $213,083,000.00 $188,811,000.00 $188,083,000.00 $187,478,000.00 $186,890,000.00 $185,544,000.00 $184,761,000.00 $184,085,000.00 $3,044,000.00 -- $2,536,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $1,000.00 $6,000.00 $-2,000.00 $-1,000.00 $-2,000.00 $-1,000.00 $7,000.00 $17,000.00 $24,000.00 -- $-5,000.00 $-3,000.00 $-12,000.00 $-50,000.00 $-33,000.00 $-6,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-238,657,000.00 $-231,953,000.00 $-219,292,000.00 $-214,296,000.00 $-209,273,000.00 $-204,883,000.00 $-198,135,000.00 $-190,900,000.00 $-183,151,000.00 $-175,979,000.00 $-168,493,000.00 $-161,459,000.00 $-154,025,000.00 $-144,534,000.00 $-136,946,000.00 $-130,081,000.00 $-123,822,000.00 -- $-114,342,000.00 -- -- -- -- --
Total Stockholders' Equity $50,109,000.00 $56,130,000.00 $12,162,000.00 $12,458,000.00 $16,654,000.00 $9,769,000.00 $16,048,000.00 $22,816,000.00 $29,984,000.00 $12,847,000.00 $19,600,000.00 $26,031,000.00 $32,868,000.00 $40,975,000.00 $47,797,000.00 $54,013,000.00 $-120,778,000.00 -- $-111,806,000.00 -- -- -- $-94,319,000.00 $-82,044,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $54,768,000.00 $60,531,000.00 $16,341,000.00 $22,239,000.00 $26,125,000.00 $20,373,000.00 $26,473,000.00 $33,952,000.00 $40,193,000.00 $22,399,000.00 $30,312,000.00 $38,133,000.00 $42,577,000.00 $45,831,000.00 $52,688,000.00 $59,036,000.00 $15,105,000.00 -- $22,021,000.00 -- -- -- -- --

Statement of Operations

Date 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 12/31/2014
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $12,447,000.00 $8,169,000.00 $11,166,000.00 $9,241,000.00 $2,488,000.00 $4,069,000.00 $4,709,000.00 $4,475,000.00 $8,478,000.00 $4,174,000.00 $18,448,000.00 $4,321,000.00 $10,166,000.00 $4,846,000.00 $4,311,000.00 $3,825,000.00 $3,161,000.00 $2,942,000.00 $10,276,000.00 $7,184,000.00 $4,579,000.00 $2,493,000.00 $7,832,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $6,791,000.00 $12,998,000.00 $4,192,000.00 $16,304,000.00 $4,400,000.00 $6,876,000.00 $7,348,000.00 $22,607,000.00 $14,692,000.00 $7,313,000.00 $6,982,000.00 $7,498,000.00 $9,659,000.00 $7,763,000.00 $7,041,000.00 $6,426,000.00 $4,952,000.00 $4,589,000.00 $4,448,000.00 $4,232,000.00 $5,550,000.00 $3,939,000.00 $12,891,000.00 --
Loss from Operations $-19,789,000.00 $-12,998,000.00 $-20,496,000.00 $-16,304,000.00 $-11,276,000.00 $-6,876,000.00 $-29,956,000.00 $-7,915,000.00 $-14,692,000.00 $-7,313,000.00 $-6,982,000.00 $-7,498,000.00 $-9,659,000.00 $-7,763,000.00 $-23,008,000.00 $-6,426,000.00 $-9,541,000.00 $-4,589,000.00 $-18,169,000.00 $-13,721,000.00 $-5,550,000.00 $-3,939,000.00 $-12,891,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 -- 143,500,000 -- -- -- -- --
Common Stock Shares Outstanding 90,572,555 90,527,914 43,804,175 39,874,847 39,261,576 27,810,358 27,810,358 27,810,358 26,713,617 14,875,035 14,748,475 14,737,402 14,737,402 14,734,383 14,723,818 14,718,787 450,937 -- 432,413 -- -- -- -- --
Common Stock Value $91,000.00 $90,000.00 $44,000.00 $40,000.00 $39,000.00 $28,000.00 $28,000.00 $28,000.00 $28,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00 -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 -- $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2022 PursePoor.com